share_log

三葉草生物-B:董事會會議延期

CLOVER BIO-B: POSTPONEMENT OF BOARD MEETING DATE

HKEX ·  Mar 23 23:02

Summary by Moomoo AI

三葉草生物製藥宣布,原定於2025年3月24日舉行的董事會會議將延期至2025年3月31日。延期原因是公司需要更多時間落實2024年度業績。該次董事會會議主要目的是考慮及批准截至2024年12月31日止年度之全年業績,並評估是否派付末期股息。
三葉草生物製藥宣布,原定於2025年3月24日舉行的董事會會議將延期至2025年3月31日。延期原因是公司需要更多時間落實2024年度業績。該次董事會會議主要目的是考慮及批准截至2024年12月31日止年度之全年業績,並評估是否派付末期股息。
Sanchu Grass Biopharmaceuticals announced that the Board of Directors meeting originally scheduled for March 24, 2025, will be postponed to March 31, 2025.The reason for the delay is that the company needs more time to implement the 2024 fiscal performance. The main purpose of this Board of Directors meeting is to consider and approve the full-year performance for the year ending December 31, 2024, and to assess whether to pay a final dividend.
Sanchu Grass Biopharmaceuticals announced that the Board of Directors meeting originally scheduled for March 24, 2025, will be postponed to March 31, 2025.The reason for the delay is that the company needs more time to implement the 2024 fiscal performance. The main purpose of this Board of Directors meeting is to consider and approve the full-year performance for the year ending December 31, 2024, and to assess whether to pay a final dividend.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 264

Recommended

Statement

This page is machine-translated. Moomoo tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.